This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13 2009-11-23 09:25 ET - News Release NEWPORT BEACH, Calif., Nov. 23, 2009 (GLOBE NEWSWIRE) -- BUYINS.NET, www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hemispherx Biopharma (AMEX:HEB) after releasing the latest short sale data to November 20, 2009. From January 2005 to November 2009 approximately 1.39 billion total aggregate shares of HEB have traded for a total dollar value of nearly $2.97 billion. The total aggregate number of shares shorted in this time period is approximately 75.5 million shares. There have been nearly 26 million shares shorted in 2009 alone. The next short squeeze is expected to begin when shares of HEB close above $1.13, where over 2.8 million shares have been shorted. The following chart shows the monthly SqueezeTrigger levels where short sellers go out-of-the-money on their trades and are most likely to start covering.
The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page